US 9670215
Compounds useful as inhibitors of ATR kinase
granted A61PA61P35/00A61P43/00
Quick answer
US patent 9670215 (Compounds useful as inhibitors of ATR kinase) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61P, A61P35/00, A61P43/00